- Medical Devices
- Thursday, 07 Nov 2019
3D Systems Expands its Industry-Leading Portfolio of Dental Materials with Newly FDA-Cleared NextDent® Denture 3D+
3D Systems (NYSE:DDD) announced that its new biocompatible denture material, NextDent® Denture 3D+, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The combination of this new dental 3D printing material, NextDent 5100 dental 3D printer, and industry-leading intra-oral scanning and dental software solutions yields an end-to-end digital dentistry solution. As a result, customers can expect more precise, predictable results than through analog techniques - enabling more efficient, cost-effective creation of dentures for patients.
Producing a denture using NextDent Denture 3D+ for the base, and NextDent C&B MFH for the teeth on the NextDent 5100 results in a final denture that is 90% less expensive to produce in 75% less time than dentures created using analog methods. The digital solution improves the patient experience as well, providing a properly fitting device with fewer required office visits.
“With 3D Systems’ Digital Denture Workflow, dental laboratories and clinics are now able to produce dental devices at dramatically increased speed while reducing material waste and capital equipment expenditure as well as reliance upon milling centers,” said Rik Jacobs, vice president, general manager, dental, 3D Systems. “FDA clearance of NextDent Denture 3D+ is the last piece that creates a trusted end-to-end workflow – giving prosthodontists a competitive advantage while improving the patient experience.”
NextDent Denture 3D+ material possesses excellent mechanical properties (in accordance with ISO Denture Base Standards) and is capable of producing dentures rivaling conventional denture base materials. 3D Systems offers the largest available color palette for a denture base material, which enables dental labs and clinics to deliver a final product that most closely matches a patient’s gums for a natural looking aesthetic. This material joins the company’s portfolio of 30 unique NextDent resins – the largest number available from any dental 3D printing material supplier. NextDent 3D printing materials for medical devices are biocompatible and CE certified (CE certification is pending for NextDent Denture 3D+) in accordance with Medical Device Directive 93/42/EEC, listed at the FDA, and registered in various other countries. The complete NextDent portfolio – for both medical and non-medical devices – is suitable for a wide range of applications.
Related Industry Updates
Laboratory Proficiency Testing Market 2021 Growth and Forecast By Merck, FAPAS, Waters Corporation, QACS, Weqas
Apr 13, 2021
Marijuana Drying and Curing Equipment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Marijuana Type (Medical Marijuana, Recreational Marijuana and Other Types); Product Type (Buds, Oil, Tinctures, and Other Product Types); Application (Cancer, Chronic Pain, Mental Disorders, and Other Applications), and Geography
Apr 28, 2021
Vyaire Medical and Spirit AeroSystems Partner to Greatly Increase Ventilator Production in Response to COVID-19 Pandemic
May 05, 2020
Surgical Snare Market (2022-2028) Business Outlook and Global Market Assessment
Apr 12, 2023
Tissue Diagnostics Market Technological Advancements and Product Innovations
Mar 23, 2023
Pharmaceutical Robots See Growing Awareness and Increase in Investments
Aug 28, 2019
Monocyte Activation Tests Market is expected to reach US$ 236,714.17 thousand by 2030
Dec 05, 2023